Phase 3 Epilepsy trials recruiting now

All Epilepsy trials, every phase

Other phases for Epilepsy

Phase 3 Epilepsy trials

• A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
  NCT07019922 · Phase: Phase 3 · Ages: 1 Day to 18 Years · Sex: All (male and female) · 10 locations
• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
  NCT06872125 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 61 locations
• A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
  NCT06660394 · Phase: Phase 3 · Ages: 2 Years to 65 Years · Sex: All (male and female) · 104 locations
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
  NCT05716100 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 95 locations
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · 68 locations
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 124 locations
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 138 locations
• A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
  NCT07594158 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 1 location
• A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
  NCT04715646 · Phase: Phase 3 · Ages: 1 Month and older · Sex: All (male and female) · 36 locations
• An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
  NCT05066217 · Phase: Phase 3 · Ages: 2 Years to 55 Years · Sex: All (male and female) · 58 locations
• Biperiden Trial for Epilepsy Prevention
  NCT04945213 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 10 locations
• Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
  NCT07668856 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female) · 1 location
• Exogenous Ketone Esters for Drug Resistant Epilepsy
  NCT05670847 · Phase: Phase 2, Phase 3 · Ages: 1 Year to 16 Years · Sex: All (male and female) · 1 location
• Exogenous Ketone Esters for Refractory Status Epileptics
  NCT05674552 · Phase: Phase 2, Phase 3 · Ages: 1 Year to 10 Years · Sex: All (male and female) · 1 location
• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  NCT05219617 · Phase: Phase 3 · Ages: 4 Years to 55 Years · Sex: All (male and female) · 71 locations
• Ketogenic Diet for New-Onset Absence Epilepsy
  NCT04274179 · Phase: Phase 3 · Ages: 3 Years to 12 Years · Sex: All (male and female) · 1 location
• LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
  NCT07234695 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · 5 locations
• Lemborexant Treatment of Insomnia Linked to Epilepsy
  NCT06262594 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Levetiracetam Three Times Daily in Epilepsy
  NCT07490769 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Levetiracetam for Seizure Prevention After Brain Tumor Surgery
  NCT07239115 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
  NCT05431595 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
  NCT06579573 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 25 locations
• Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
  NCT05534672 · Phase: Phase 3 · Ages: 3 Months to 50 Years · Sex: All (male and female) · 2 locations
• Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)
  NCT07095842 · Phase: Phase 2, Phase 3 · Ages: 2 Years to 16 Years · Sex: All (male and female) · 1 location
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
  NCT07594119 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 11 locations
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
  NCT07563881 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 11 locations
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 35 locations
• TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders
  NCT07377032 · Phase: Phase 3 · Ages: 2 Years to 30 Years · Sex: All (male and female) · 3 locations
• Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
  NCT07403266 · Phase: Phase 3 · Ages: 2 Years to 65 Years · Sex: All (male and female) · 2 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.